Abstract:In most western countries, carcinoma of the prostate is the second most frequent cause of cancer death following carcinoma of the lung. In the pathogenesis of clinical carcinoma of the prostate, several mutational steps can be distinguished which correlate with subclinical and clinical situations. Focal carcinoma is identified in autopsy series at least 500-1,000 times more than is appreciated on clinical grounds alone. Still, focal carcinoma must be considered the precursor of all clinical disease. At least three mutational steps must be involved in the pathogenesis: the development of focal carcinoma from normal cells, the progression to hormone-dependent clinical carcinoma, and the progression to hormone-independent carcinoma. The geographic variation of these events suggests that exogenous factors play an important role in the pathogenesis of prostatic cancer. Focal, noninvasive carcinoma is found in the clinical situation incidentally upon treatment of obstruction in 8-12% of cases with benign prostatic hyperplasia. This lesion is usually not treated aggressively. The incidence of clinical prostatic carcinoma is strictly age-related. Because the tumor largely occurs after age 50, and competing causes of death play an important role, only about 50% of all patients with clinical prostatic carcinoma are likely to die of this disease. Prostatic carcinoma is most frequently diagnosed in the metastatic state (40-50%). The remainder are locally confined with an incidence of lymph node metastases of roughly 35%. Tumors diagnosed in the metastatic state have a distinctly poorer prognosis than tumors diagnosed as potentially curable lesions. Metastatic prostatic carcinoma is usually managed by means of androgen suppression. Hormone-dependent human tumor lines in nude mice suggest that endocrine-dependent cells are not killed by androgen withdrawal, but remain dormant and can be restimulated to grow. In the same sense, management of prostatic carcinoma appears to be palliative. Patients die of prostatic carcinoma because hormone-independent cell populations develop and cannot be influenced by hormonal management. Still-open questions concerning endocrine management are the timing of androgen withdrawal (early versus delayed) and the degree of androgen withdrawal (total versus subtotal). Luteinizing hormone-releasing hormone (LHRH) agonists and antiandrogens allow endocrine management with minimal side effects. Prolongation of life and cure can only be expected from simultaneous effective treatment of hormone-independent tumor cell populations.

Hormonal Carcinogenesis in Syrian Hamsters: A Hypothesis Involving Glutathione S-Transferase Regulation

Intrahepatic Cholangiocarcinoma Induced by Aminopyrine and Sodium Nitrite in Syrian Hamsters

The hamster cheek pouch model for field cancerization studies

Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy

Current Concepts in the Management of Prostatic Cancer

Superoxide Dismutase and Catalase Levels During Estrogen-Induced Renal Tumorigenesis, in Renal Tumors and Their Autonomous Variants in the Syrian Hamster.

In vitro characterization of estrogen induced Syrian hamster renal tumors: comparison with an immortalized cell line derived from diethylstilbestrol-treated adult hamster kidney

P53 Alterations in Chemically Induced Hamster Cheek-Pouch Lesions

Protection of Sperm Dna Against Oxidative Stress in Vivo by Accessory Sex Gland Secretions in Male Hamsters

The respiratory epithelium. VI. Histogenesis of lung tumors induced by benzo[a]pyrene-ferric oxide in the hamster

Blood-Testis Barrier and Sperm Delayed in the Cauda Epididymis of the Reproductively Regressed Syrian Hamsters

Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease

Male genital tract antioxidant enzymes: their source, function in the female, and ability to preserve sperm DNA integrity in the golden hamster.

Establishment of animal model of pancreatic carcinoma in Syrian golden hamsters

Effectiveness of selenium in maintaining morphological architecture of prostatic compartments in mongolian gerbil

Age related changes in selenium and glutathione levels in different lobes of the rat prostate

Cell Proliferation and Lipid Formation in Hamster Sebaceous Gland Cells

[Molecular pathways of pancreatic carcinogenesis]

SAT354 Molecular and Histological Characterization of a Guinea Pig Model of Mild Hyperandrogenemia

Hypothesis: Cancer Hormesis and Its Potential for Cancer Therapeutics

The implication of distal lymphatic structures, milky spots in the omentum on dissemination and metastasis of pancreatic cancer in syrian golden hamster model